RE:RE:RE:New Press Release - Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2Obviously based on where the stock is you are right and I am wrong...but the facts are that what Seckler has done in 3 quarters is cut overhead and op costs significantly, sell assets and reduce debt, re-jig the Biodex facility to streamline ops and increase capacity, annouce further divestiture of the rest of the non-core assets to eliminate all the acquisition debt, also announse that the revolver will be paid off over next two quarters from CF, while at the same time opening sales into the USVA and Asia. So I am not sure what he has promised that he hasn't followed through on? Again I am just stating facts and not here to argue because the mkt is telling us what they think. If you like turnaround stories I am not sure what is not to like here. Time will tell soon.